» Authors » Jose L Molinuevo

Jose L Molinuevo

Explore the profile of Jose L Molinuevo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 3763
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sobregrau P, Peri J, Sanchez Del Valle R, Molinuevo J, Barra B, Pintor L
J Alzheimers Dis Rep . 2022 Oct; 6(1):461-478. PMID: 36186729
Background: Predictive genetic tests are presently effective over several medical conditions, increasing the demand among patients and healthy individuals. Considering the psychological burden suspected familial dementia may carry on individuals,...
2.
Shi L, Winchester L, Westwood S, Baird A, Anand S, Buckley N, et al.
Alzheimers Dement . 2021 Apr; 17(9):1452-1464. PMID: 33792144
Introduction: This study sought to discover and replicate plasma proteomic biomarkers relating to Alzheimer's disease (AD) including both the "ATN" (amyloid/tau/neurodegeneration) diagnostic framework and clinical diagnosis. Methods: Plasma proteins from...
3.
Sala-Vila A, Arenaza-Urquijo E, Sanchez-Benavides G, Suarez-Calvet M, Mila-Aloma M, Grau-Rivera O, et al.
Am J Clin Nutr . 2021 Mar; 113(6):1627-1635. PMID: 33733657
Background: The number of APOE-ε4 alleles is a major nonmodifiable risk factor for sporadic Alzheimer disease (AD). There is increasing evidence on the benefits of dietary DHA (22:6n-3) before the...
4.
Shi L, Winchester L, Liu B, Killick R, Ribe E, Westwood S, et al.
J Alzheimers Dis . 2020 Aug; 77(3):1353-1368. PMID: 32831200
Background: Previous studies suggest that Dickkopf-1 (DKK1), an inhibitor of Wnt signaling, plays a role in amyloid-induced toxicity and hence Alzheimer's disease (AD). However, the effect of DKK1 expression on...
5.
Kivipelto M, Mangialasche F, Snyder H, Allegri R, Andrieu S, Arai H, et al.
Alzheimers Dement . 2020 Jul; 16(7):1078-1094. PMID: 32627328
Reducing the risk of dementia can halt the worldwide increase of affected people. The multifactorial and heterogeneous nature of late-onset dementia, including Alzheimer's disease (AD), indicates a potential impact of...
6.
Skouras S, Torner J, Andersson P, Koush Y, Falcon C, Minguillon C, et al.
Brain . 2020 Feb; 143(3):976-992. PMID: 32091109
Research into hippocampal self-regulation abilities may help determine the clinical significance of hippocampal hyperactivity throughout the pathophysiological continuum of Alzheimer's disease. In this study, we aimed to identify the effects...
7.
Westwood S, Baird A, Anand S, Nevado-Holgado A, Kormilitzin A, Shi L, et al.
J Alzheimers Dis . 2020 Jan; 74(1):213-225. PMID: 31985466
We have previously investigated, discovered, and replicated plasma protein biomarkers for use to triage potential trials participants for PET or cerebrospinal fluid measures of Alzheimer's disease (AD) pathology. This study...
8.
Stamate D, Kim M, Proitsi P, Westwood S, Baird A, Nevado-Holgado A, et al.
Alzheimers Dement (N Y) . 2020 Jan; 5:933-938. PMID: 31890857
Introduction: Machine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer Disease (AD). Here we set out to test the performance of metabolites in blood to...
9.
Ashton N, Suarez-Calvet M, Heslegrave A, Hye A, Razquin C, Pastor P, et al.
Alzheimers Res Ther . 2019 Nov; 11(1):94. PMID: 31779670
Background: Results from recent clinical studies suggest that cerebrospinal fluid (CSF) biomarkers that are indicative of Alzheimer's disease (AD) can be replicated in blood, e.g. amyloid-beta peptides (Aβ and Aβ)...
10.
Brugulat-Serrat A, Salvado G, Operto G, Cacciaglia R, Sudre C, Grau-Rivera O, et al.
Hum Brain Mapp . 2019 Nov; 41(5):1309-1322. PMID: 31778002
White matter hyperintensities (WMH) have been extensively associated with cognitive impairment and reductions in gray matter volume (GMv) independently. This study explored whether WMH lesion volume mediates the relationship between...